BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc/ US09061G1013 /
BMRN
2024-03-18 9:00:00 PM
|
Chg.
-0.0600
|
Volume |
Bid12:03:51 AM |
Ask12:03:51 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
83.8100USD
|
-0.07%
|
1.4 mill. Turnover: 76.02 mill. |
82.0800Bid Size: 100 |
85.2600Ask Size: 300 |
15.81 bill.USD |
- |
94.17 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
0.89 USD |
17.11% |
EPS Diluted: |
0.87 USD |
16.00% |
Revenues per Share: |
12.82 USD |
14.11% |
Book Value per Share: |
26.24 USD |
6.34% |
Cash Flow per Share: |
0.84 USD |
-10.49% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
2,419.23 USD |
15.42% |
Net Income: |
167.65 USD |
18.43% |
Operating Cash Flow: |
159.26 USD |
- |
Cash and Cash Equivalents: |
755.13 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
94.17 |
108.34 |
P/S Ratio: |
6.54 |
7.52 |
P/BV ratio: |
3.19 |
3.67 |
P/CF Ratio: |
99.29 |
114.23 |
PEG: |
5.51 |
6.33 |
Earnings Yield: |
1.06% |
0.92% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
15.81 bill. USD |
18.19 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
188.68 mill. |
|
Profitability
Gross Profit Margin: |
78.72% |
EBIT Margin: |
6.54% |
Net Profit Margin: |
6.93% |
Return on Equity: |
3.39% |
Return on Assets: |
2.45% |
Financial Strength
Liquidity I / Cash Ratio: |
64.16% |
Liquidity II / Quick Ratio: |
118.00% |
Liquidity III / Current Ratio: |
251.15% |
Debt / Equity Ratio: |
38.17% |
Dynam. Debt / Equity Ratio: |
1,186.78% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
US GAAP |